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Abstract
Ivermectin (or Mectizan™) is widely used by onchocerciasis and lymphatic filariasis control
programs worldwide. Generally, Mectizan™ is both safe and well tolerated. An exception to this
general pattern is in some areas co-endemic for Onchocerca volvulus and Loa loa, where a number
of severe adverse reactions to Mectizan™ have been noted in L. loa infected individuals. The vast
majority of these severe adverse events have occurred in Southern Cameroon. This suggested the
hypothesis that the parasites endemic to Southern Cameroon might form a distinct population that
exhibited a phenotype of eliciting severe adverse reactions in Loa-infected individuals upon
Mectizan™ exposure. To test this hypothesis, the DNA sequences of three potentially
polymorphic loci were compared among L. loa parasites from Southern Cameroon and other
endemic foci in Sub-Saharan Africa. Analysis of these data suggested that parasites from Southern
Cameroon were at least as genetically diverse as those from other foci. Furthermore, no
polymorphisms were noted that were unique to and shared among the parasite isolates from
Southern Cameroon. Although a limited number of parasite isolates were tested, these results do
not appear to support the hypothesis that L. loa parasites from Southern Cameroon represent a
unique, genetically isolated population.
Findings
Ivermectin (Mectizan™) is a semi-synthetic lactone drug
that exhibits broad anti-helminthic specificity [1]. Mecti-
zan™ has become the drug of choice for mass chemother-
apy campaigns to eliminate onchocerciasis as a public
health problem [2]. In general, these mass chemotherapy
projects have been associated with few complications. A
notable exception occurs in some areas where the agent of
onchocerciasis, Onchocerca volvulus, is sympatric with Loa
loa, the causative agent of another filarial infection of
humans. Over the past several years, severe adverse reac-
tions to Mectizan™ treatment have been reported in indi-
viduals residing in onchocerciasis endemic areas that are
also endemic for L. loa [3-5]. These adverse reactions are
characterized by severe neurological complications,
including incontinence, coma, and in some cases, death
of the patient [3,5]. Interestingly, a large majority of the
individuals suffering from such severe adverse reactions
have resided in Southern Cameroon [6-8]. The develop-
ment of severe reactions to Mectizan™ in L. loa infected
individuals has had a negative impact on the design and
implementation of Mectizan™ distribution campaigns to
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control onchocerciasis in areas where O. volvulus and L. loa
are co-endemic [9].
Parasitological examinations of patients who developed
post-Mectizan™ encephalopathy showed a correlation
between the risk of developing such reactions and the L.
loa microfilarial load [10]. However, the finding that the
vast majority of such severe reactions occurred in a local-
ized geographic area also suggested that the parasites
endemic to this area might represent a genetically distinct
population that is particularly capable of inducing adverse
reactions in the host upon being exposed to Mectizan™. If
the parasites from Southern Cameroon represent a genet-
ically distinct population, it would follow that genetic
exchange with other parasite populations would be
expected to be limited or non-existent. Such reproduc-
tively isolated populations often suffer from a genetic
founder effect, resulting in a population in which the level
of genetic heterogeneity is severely limited, and in which
the distribution of alleles in the isolated population is
often strikingly different from that seen in non-reproduc-
tively isolated populations. Furthermore, prolonged
reproductive isolation of a population will result in the
accumulation of population specific genetic polymor-
phisms. If this occurs, phylogenic analyses based upon
data collected from isolates from within and outside of
the isolated population should result in a phylogeny in
which the isolates from within the isolated population are
grouped together.
Very little is known concerning the degree of genetic diver-
sity among different populations of L. loa and the role that
such genetic polymorphisms may play in the adverse
responses to Mectizan™ treatment. Simian and human
strains of L. loa, which differ in the length of the micro-
filariae and their periodicity in the host have long been
recognized [11,12]. Despite these differences, human and
simian L. loa are believed to be the same species, as exper-
imental studies have shown that parasites from these two
primate hosts can hybridize [12]. Because parasites from
the two hosts differ in periodicity and are transmitted by
different species of the Chrysops genus, it has been pro-
posed that the human and simian parasites "are at an early
stage of radiative evolution" [11]. Whether hybridization
of the simian and human strains is a co-factor in the devel-
opment of post-Mectizan™ encephalopathy is unknown
[13]. Some biochemical variation has also been reported
among different populations of human L. loa [14],
although these differences have not been explored at the
genetic level.
Perhaps the most well documented case of the importance
of genetic factors in the pathogenesis of a human filarial
infection is in onchocerciasis. Human onchocerciasis
exhibits two distinct clinical and epidemiologic disease
patterns in the rain forest and savanna bioclimes of West
Africa [15,16]. Studies have revealed a strong correlation
between the classification based upon the epidemiologi-
cal disease pattern and the pattern of hybridization to
strain specific DNA sequences derived from a repeated
sequence encoded in the nuclear genome of O. volvulus
[17]. Subsequent studies have demonstrated that varia-
tion within this repeat population could be used as a tool
for biogeographic studies [18,19]. In Ascaris suum [20],
Ostertagia osteragi [21] and Haemonchus contortus [22]
mitochondrially encoded sequences have proven to con-
tain useful polymorphisms for population based studies.
Similarly, the internal transcribed spacer (ITS) of the
ribosomal RNA gene cluster has been used to develop
markers capable of distinguishing different populations
of Haemonchus contortus [23].
To test the hypothesis that L. loa endemic to Southern
Cameroon represents a distinct population, four parasite
isolates were obtained from Southern Cameroon. These
parasites consisted of infective larvae obtained from four
individual wild caught L. loa infected Chrysops dimidiata
vector flies collected in the village of Ngat (3°25'N,
11°33'E), located approximately 50 km south of the cap-
ital of Yaoundé. Previous studies have reported cases of L.
loa encephalopathy in this village [24]. Individual isolates
were also obtained from blood collected from L. loa
infected expatriate former residents of Nigeria, Gabon and
The Democratic Republic of the Congo at the Laboratory
of Parasitic Diseases at the National Institutes of Health in
Bethesda, MD, USA. DNA was extracted from the parasite
preparations, following previously described methods
[25]. These DNA samples were then used as templates in
PCR amplification reactions targeting three gene
sequences: the mitochondrial 16S rRNA gene, the ITS2
domain of the nuclear rRNA gene cluster, and the 15r3
polyprotein gene in L. loa. The 15r3 gene has previously
been shown to be polymorphic and useful in the develop-
ment of a DNA based diagnostic assay for this parasite
[26,27]. These gene sequences were chosen for study
because, as discussed above, homologues (or related
sequences) have previously been shown to be informative
population based markers in studies of other parasitic
nematodes. PCR amplicons resulting from these reactions
were subjected to direct DNA sequence analysis to identify
sequence polymorphisms.
All of the DNA templates were successfully amplified with
the primer set derived from the mitochondrial 16S rRNA
gene. However, no polymorphisms were noted in the
amplification products analyzed (data not shown).
Amplification products were also obtained from all of the
samples targeting the 15r3 polyprotein gene. Several pol-
ymorphic sites were found in the 15R3 amplicons. Inter-
estingly, sequences derived from DNA extracted from theFilaria Journal 2004, 3:4 http://www.filariajournal.com/content/3/1/4
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Analysis of polymorphisms in the 15r3 and ITS2 gene sequences of L. loa Figure 1
Analysis of polymorphisms in the 15r3 and ITS2 gene sequences of L. loa: Panel A: Pairwise differences in 15r3 amplicon 
sequences among L. loa isolates. The 15R3 gene fragment was amplified from L. loa genomic DNA (2.5 µl per reaction) using 
primers with the sequences 5' GGCACAAAACACTGCAGCAGTCCT 3' and 5' CAGCTGTCTCAAATCGAAGATTCT 3'. A 
total of 2.5 units of Taq polymerase (Roche Applied Biochemicals, Indianapolis, USA) was used in each 50 µl amplification reac-
tion, together with the reaction buffer supplied by the manufacturer. Amplification conditions consisted of an initial denatura-
tion of 5 minutes at 94°C, followed by 40 cycles consisting of 1 minute at 94°C, 1 minute at 49°C, and 2 minutes at 72°C. 
Reactions were completed by a final extension at 72°C for 7 minutes. The amplicon analyzed was 318 nucleotides long. Dis-
tances were calculated using the two parameter method [28]. Panel B: Pairwise differences in ITS2 amplicon sequences among 
L. loa isolates. The ITS2 gene fragment was amplified from L. loa genomic DNA (2.5 µl per reaction) using primers with the 
sequences 5' TAACAATGAAGATAAAGCGA 3' and 5' TTAGTTTCTTTTCCTCCGCT 3'. A total of 2.5 units of Taq 
polymerase (Roche Applied Biochemicals, Indianapolis, USA) was used in each 50 µl amplification reaction, together with the 
reaction buffer supplied by the manufacturer. Amplification conditions consisted of an initial denaturation of 5 minutes at 94°C, 
followed by 40 cycles consisting of 1 minute at 94°C, 1 minute at 50°C, and 2 minutes at 72°C. Reactions were completed by 
a final extension at 72°C for 7 minutes. The amplicon analyzed was 472 nucleotides long. Distances were calculated using the 
two parameter method [28]. Panel C: Phylogenetic tree developed from the ITS2 sequence data. The phylogeny was developed 
using parsimony methods, performing an exhaustive search of the data with the parsimony routines in the PAUP program 
package (v4.0, release 10) [29]. The robustness of the phylogeny was tested by running 1000 synthetic datasets with the boot-
strap method in the PAUP program package. As indicated on the figure, the division of the four sequences into the two clades 
shown was supported 70% of the time in the bootstrap analysis.
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blood of L. loa infected individuals from Gabon, Nigeria
and The Democratic Republic of the Congo were identical
(Figure 1, Panel A). One of the isolates from Southern
Cameroon also contained a 15R3 sequence which was
identical to that found in the parasite isolates from the
other countries. However, the remaining three isolates
from Southern Cameroon contained between 3 and 7 pol-
ymorphic sites when compared to the canonical sequence
found in the other parasites (Figure 1, Panel A). These
data suggest that the 15R3 gene sequences from parasites
obtained from Southern Cameroon were at least as poly-
morphic as those from other L. loa foci in Sub-Saharan
Africa. None of the polymorphisms were consistently
found among the isolates from Southern Cameroon, sug-
gesting that these polymorphisms probably did not arise
from evolution in a genetically homogeneous, reproduc-
tively isolated population (data not shown).
Amplification of the ITS2 locus was successful from L. loa
DNA samples from Nigeria, Gabon and two of four sam-
ples from Southern Cameroon. Again, several polymor-
phisms were noted among the four samples examined
(Figure 1, Panel B). However, none of these polymor-
phisms were specific to and conserved in the two isolates
from Southern Cameroon. Thus, an analysis of the
sequence data using parsimony methods did not support
a phylogeny that grouped the two isolates from Southern
Cameroon (Figure 1, Panel C).
The data presented above are preliminary, and involve the
analysis of a limited number of sequences from a small
number of parasite isolates. Nevertheless, some conclu-
sions are suggested by these results. First, it appears that
genetic variation in parasites from the focus in Southern
Cameroon is at least as frequent as in parasites from other
locations. Second, no polymorphisms were noted which
were unique to the parasites from Southern Cameroon
and also shared among the isolates examined from this
focus. Together, these observations argue against the
hypothesis that the parasites found in Southern Cam-
eroon represent a distinct, reproductively isolated popula-
tion. Analysis of additional parasite samples and
additional loci will be necessary to confirm this.
This study revealed a considerable amount of sequence
variation in the two nuclearly encoded genes examined. If
this level of sequence heterogeneity is representative of
the rest of the nuclear genome, this suggests that the L. loa
population from Southern Cameroon is fairly genetically
heterogeneous. It is therefore possible that a proportion of
the parasites from Southern Cameroon contain allelic var-
iants of genes that result in enhanced virulence and/or
pathogenicity in the face of Mectizan™ treatment. This
might explain the fact that severe adverse reactions in
response to Mectizan™ treatment are confined to a small
proportion of the treated population. To test this hypoth-
esis, it will be necessary to obtain parasites from individu-
als who exhibit the preliminary symptoms of a severe
adverse reaction shortly following Mectizan™ distribu-
tion, when L. loa microfilariae are still likely to be present
in the circulation.
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